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PURPOSE. To investigate fluorescence lifetime characteristics in patients with geographic
atrophy (GA) in eyes with age-related macular degeneration and to correlate the
measurements with clinical data and optical coherence tomography (OCT) findings.
METHODS. Patients with GA were imaged with a fluorescence lifetime imaging ophthalmo-
scope. Retinal autofluorescence lifetimes were measured in a short and a long spectral
channel (498–560 nm and 560–720 nm). Mean retinal fluorescence lifetimes were analyzed
within GA and the surrounding retina, and data were correlated with best corrected visual
acuity and OCT measurements.
RESULTS. Fluorescence lifetime maps of 41 eyes of 41 patients (80 6 7 years) with GA were
analyzed. Mean lifetimes within areas of atrophy were prolonged by 6246 276 ps (þ152%) in
the short spectral channel and 418 6 186 ps (þ83%) in the long spectral channel compared
to the surrounding tissue. Autofluorescence lifetime abnormalities in GA occurred with
particular patterns, similar to those seen in fundus autofluorescence intensity images. Within
the fovea short mean autofluorescence lifetimes were observed, presumably representing
macular pigment. Short lifetimes were preserved even in the absence of foveal sparing but
were decreased in patients with advanced retinal atrophy in OCT. Short lifetimes in the fovea
correlated with better best corrected visual acuity in both spectral channels.
CONCLUSIONS. This study established that autofluorescence lifetime changes in GA present with
explicit patterns. We hypothesize that the short lifetimes seen within the atrophy may be used
to estimate damage induced by atrophy and to monitor disease progression in the context of
natural history or interventional therapeutic studies.
Keywords: fundus autofluorescence, fluorescence lifetimes, ophthalmic imaging, GA,
geographic atrophy, AMD, age-related macular degeneration
Geographic atrophy (GA) is the end stage of dry age-relatedmacular degeneration (AMD) and is characterized by slow
and progressing degeneration of the retinal pigment epitheli-
um, the choriocapillaris, and the outer retina.1 Advanced dry
AMD with GA leads to progressive irreversible loss of central
vision and is one of the leading causes for blindness,2
accounting for up to 20% of severe vision loss in North
America.3 Despite being a thoroughly investigated and clinically
well characterized disease, the molecular pathways leading to
atrophy in dry AMD are complex and multifactorial. Epidemi-
ologic studies have identified advanced age, smoking, and
nutrition as risk factors for the development of GA. Further-
more, certain complement pathway genes including comple-
ment component 3 and complement factor H and I have been
shown to be risk factors for the development and progression
of AMD.4,5
Recent advances in retinal imaging technologies have
improved the understanding of morphological changes that
occur in complex-trait macular diseases such as GA. Fundus
autofluorescence (FAF) imaging allows a refined measurement
of the GA area, disease progression, and characterization of GA
phenotypes.6,7 Longitudinal observations have shown that the
latter has an impact on atrophy and therefore can be used as a
prognostic determinant.8
The fundus autofluorescence signal is mainly generated by
RPE lipofuscin, a mixture of fluorophores originating from by-
products of the visual cycle.9,10 As a result of RPE loss and the
subsequent decrease of lipofuscin that occurs in advanced GA,
there is a loss of signal in the FAF. However, in the junctional
zone surrounding atrophy, FAF has been shown to be increased.
The increased autofluorescence signal could be a result of
increased phagocytosis with lipofuscin accumulation or forma-
tion of RPE multilayers.11,12 Alternatively, increased bisretinoid
formation within impaired photoreceptors has been proposed
to be causative for increased autofluorescence in the junctional
zone.13
High-resolution optical coherence tomography (OCT) has
advanced the study of GA with its unprecedented resolution,
and thus it has provided further insights in the disease process
and has been reported to be useful to identify areas of foveal
sparing.14 OCT characteristics of GA include choroidal signal
enhancement and alterations at the level of RPE, the outer
nuclear layer (ONL) and outer plexiform layer (OPL), and the
external limiting membrane.
Time-resolved fundus autofluorescence imaging (FLIO) is a
relatively novel imaging method that allows topographic
mapping of endogenous fluorescence lifetimes within the
retina.15–17 The fluorescence lifetime represents the time a
molecule spends in its excited state after excitation with a laser
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impulse before returning to its ground state by emission of a
photon with a longer wavelength. Autofluorescence lifetimes
are specific for each fluorophore and sensitive to the metabolic
environment.18
The aim of the present study was to characterize
autofluorescence lifetimes in GA as a result of AMD and to
identify GA phenotypes using FLIO and high-resolution
spectral-domain OCT imaging.
METHODS
This study is registered at ClinicalTrials.gov (NCT01981148). It
was carried out with the approval of the local ethics committee
and is in accordance with the International Ethical Guidelines
for Biomedical Research involving Human Subjects (Council for
International Organizations of Medical Sciences) and the
Declaration of Helsinki.
Patients
Patients with GA and AMD were recruited at the Outpatient
Department of Ophthalmology at the Bern University Hospital,
Bern, Switzerland, and signed an informed consent prior to
study entry. None of the patients reported taking carotenoid
supplementation.
Patient selection was relayed on the clinical diagnosis that
was confirmed by OCT and FAF imaging. Eyes with a history or
signs of neovascular AMD and other ophthalmic diseases
affecting the macula as well as significant lens opacities were
excluded.
Geographic Atrophy
Areas of GA were defined funduscopically with clearly visible
marked boundaries of decreased retinal pigmentation and
exposed underlying choroidal structures. In FAF, one or more
clearly demarked areas of hypoautofluorescence were present,
corresponding to areas in OCT with choroidal signal enhance-
ment because of the absence of the retinal pigment epithelium
and loss of the external limiting membrane within the fovea.
Foveal sparing was defined as a central foveal island with an
intact retinal layer structure that was preserved and surround-
ed by well-demarked areas of GA for at least 2708.
Patient Examinations
For all of the patients included in this study, best corrected
visual acuity (BCVA) was assessed (Early Treatment Diabetic
Retinopathy Study [ETDRS] letters).19 Subsequently, pupils
were maximally dilated with tropicamid 0.5% and phenyleph-
rine hydrochloride 2.5%, and the fundus was examined
biomicroscopically. Color fundus images (Zeiss FF 450plus,
Zeiss, Oberkochen, Germany), FAF images, and OCT scans of
the macula (Heidelberg Spectralis HRAþOCT; Heidelberg
Engineering, Heidelberg, Germany) were obtained. OCT was
performed using a high-speed mode and a scan pattern size of
208 3 208 centered on the fovea, resulting in 49 B scans per
eye.
Fluorescence lifetime images were acquired using a
fluorescence lifetime imaging ophthalmoscope, which is based
on an HRA Spectralis system (Heidelberg Engineering).
Fluorescence Lifetime Imaging Ophthalmoscope
The fluorescence lifetime imaging ophthalmoscope uses a 473-
nm pulsed blue laser light at an 80-MHz repetition rate for
excitation of retinal autofluorescence. Emitted fluorescence
light was registered by time-correlated single-photon counting
modules using highly sensitive hybrid photon-counting detec-
tors (Becker&Hickl, Berlin, Germany). Two detection channels
with distinct wavelengths were used: a short spectral channel
(SSC, 498–560 nm) and a long spectral channel (LSC, 560–720
nm). Simultaneously, a confocal high-contrast infrared image
was recorded by the system to record each photon at the
correct spatial location. A minimal photon count of 1000
photons per pixel was acquired for every location within the
image, resulting in a total scan duration of approximately 90
seconds. The Becker&Hickl software (SPCImage 4.6) was used
for the analysis of recorded lifetime data, and a biexponential
decay model was applied using a binning factor of one. A
triexponential fitting procedure, which requires a higher
binning factor, did not substantially contribute to a lower v2
value, which indicates the goodness of the fit. Therefore, we
used a binning of 33 3 pixels and two decay components to
gain spatial resolution.
This procedure resulted in a short (T1) and a long (T2)
lifetime component with corresponding amplitudes a1 and a2.
For each pixel, an intensity-weighted mean fluorescence
lifetime value Tm was calculated as follows:
Tm ¼ a1*T1þ a2*T2
a1þ a2 ð1Þ
The basic characteristics of the FLIO device and the analysis
method have been further described in previous reports.15
Analysis of Fluorescence Lifetime Data
Areas of GA within FAF images were classified according to
Bindewald et al.6 The size of GA was measured manually
within FAF images. Fluorescence lifetime data was further
analyzed by using the FLIO reader software (ARTORG Center
for Biomedical Engineering Research, University of Bern,
Bern, Switzerland). A circle of interest with a diameter of 0.2
mm was applied for the quantitative analysis of detailed
structures. This circle was placed within predefined areas of a
standard early treatment of a diabetic retinopathy (ETDRS)
grid with a central area (diameter [d]¼ 1 mm), an inner ring
(d ¼ 3 mm), and an outer ring (d ¼ 6 mm). Image detail
sections (d¼ 0.2 mm) were analyzed within the foveal center
and the outer ETDRS ring from the unaffected retina and areas
within GA. The image detail section measurements represent
a mean value of three individual measurement locations.
Fluorescence lifetime data of both spectral channels were
analyzed separately. If both eyes showed GA, the eye with the
better image quality was chosen.
Analysis of OCT Data
Thickness measurements of retinal layers were performed
using a spectral-domain OCT. The inbuilt automated retinal
layer segmentation of the Heidelberg software was applied.
Total retinal thickness within the foveal center was assessed
after manual correction of the automatically segmented inner
limiting membrane and the basal membrane. The values were
extracted from the central subfield of the ETDRS grid, and a
small marker was placed within the foveal center. Choroidal
thickness was measured beneath the foveal center.
Statistical Analysis
For statistical analysis, Prism Graph Pad (Prism 6; GraphPad
Software, Inc., La Jolla, CA, USA) was used. Within the outer
ring of the ETDRS grid, retinal areas within GA were compared
with surrounding retinal tissue and with lifetime values from
the foveal center. Group comparison was done by one-way
ANOVA and Tukey’s multiple-comparison posttest analysis
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(confidence interval 95%). A linear regression model was used
for correlation analysis. P values of less than 0.05 were
considered to be statistically significant. Multiple linear
regression analysis was performed using SigmaPlot Version
12.3 (Systat Software, Inc., San Jose, CA, USA).
RESULTS
A total of 41 eyes with AMD and GA of 41 patients were
analyzed (22 right eyes and 19 left eyes). The mean age 6
standard deviation of the patients was 80 6 7 years (range, 66–
94) and 54% (22) of the patients were female. Of the
investigated eyes, 66% (27 patients) were pseudophacic.
Foveal sparing was seen in 24% (10 patients). The mean
area of GA (6 standard error of the mean [SEM]) was 14.0 6
1.8 mm2 (range, 0.2–50 mm2). Of the investigated eyes, 34%
(14 patients) showed one isolated unifocal lesion, whereas 66%
(27 patients) presented with multiple areas of GA. Multifocal
lesions were either grouped in main atrophy with satellite
lesions (37%, 10 patients) or multiple confluent atrophic areas
(63%, 17 patients). According to GA classification of Bindewald
et al.,6 10% of the eyes (4 patients) showed no increased
autofluorescence surrounding GA, 10% (4 patients) presented
with focal, 49% (20 patients) with diffuse (reticular, branching,
fine granular, trickling, granular with peripheral punctuate
spots), 29% (12 patients) with banded, and 2% (1 patient) with
patchy hyperfluorescence.
Fluorescence Lifetimes in GA
Representative images of a patient with GA are shown in Figure
1. Areas of decreased autofluorescence intensity in FAF
correlated well with the areas of abnormal mean fluorescence
lifetime values. Different patterns of GA were associated with
specific autofluorescence lifetime patterns (Fig. 2). The mean
fluorescence lifetime measured in areas of GA was 1035 6 52
ps (SEM) in the SSC and 924 6 36 ps in the LSC (Fig. 3).
Therefore, Tm was significantly prolonged by 624 6 276 ps
(þ152%) in the SSC and 418 6 186 ps (þ83%) in the LSC when
compared with the surrounding retinal tissue with mean
lifetimes of 411 6 11 ps and 506 6 10 ps, respectively (P <
0.0001). The coefficient of variation in the SSC was 17% for the
retina and 31% within GA, and in the LSC it was 13% in the
retina and 24% within GA. Within GA, the mean autofluores-
cence lifetime of the foveal center was shorter when compared
with the surrounding atrophic area (Figs. 1–4), irrespective of
foveal sparing (Fig. 5). In seven eyes with progressed atrophy
of the outer retinal layers in OCT, the mean fluorescence
lifetime distribution did not show a peak of short lifetimes
within the macular center but, rather, a speckled pattern (Figs.
6A, 6B).
Fluorescence Lifetimes in Pseudophakic Versus
Phakic Patients
In the SSC, the mean fluorescence lifetime values were
significantly dependent on the lens status (P ¼ 0.05 in the
foveal center, <0.001 in the normal retina, and 0.003 in GA
areas; multiple linear regression analysis). In the LSC, the
values were completely independent of the lens status (P ¼
0.41 in the foveal center, 0.4 in the normal retina, and 0.84 in
GA areas). However, because fluorescence lifetimes were
analyzed and compared within individual eyes, the lens status
as a potential confounder was eliminated.
Fluorescence Lifetimes in GA With Foveal Sparing
Patients with GA and foveal sparing (n¼ 10) showed uniformly
prolonged mean autofluorescence lifetimes inside the areas of
atrophy. Within the foveal center, typical short mean fluores-
cence lifetimes were observed (SSC: 295 6 27 ps; LSC: 401 6
28 ps; Fig. 5). Mean fluorescence lifetimes within the foveal
center of patients with central GA did not significantly differ
from values from patients with foveal sparing (P ¼ 0.67 and
0.31; Fig. 5B).
FLIO and Visual Acuity
The mean visual acuity in the study eyes was 42 6 3 ETDRS
letters (range, 0–84 letters). There was a significant correlation
between BCVA and the mean fluorescence lifetime of the
central ETDRS subfield in both spectral channels when
analyzing the data of all study eyes (r2 ¼ 0.19, P ¼ 0.004; Fig.
7). In a subgroup analysis of eyes with foveal sparing (n¼ 10),
r2 was 0.16 and 0.13, respectively (P ¼ 0.03 and 0.04).
FLIO and OCT Analysis
Retinal thickness within atrophic areas was clearly reduced in
eyes with GA as a result of AMD (143 6 12 lm; Figs. 1, 4–6).
Outer retinal layers, including the RPE, the photoreceptors,
and the ONL and OPL were significantly thinned or completely
missing. The RPE showed drusenoid deposits and irregularities
that appeared as highly hyper-reflective in the OCT scans.
Mean subfoveal choroidal thickness was 139 6 11 lm.
FIGURE 1. Central GA in a patient with dry AMD. CF, color fundus; AF,
fundus autofluorescence intensity LSC; FLIO SSC/LSC, mean fluores-
cence lifetime images of the short and the long spectral channels. OCT
scan of the indicated line.
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The mean retinal thickness of the central subfield showed a
weak correlation with the BCVA, whereby increased retinal
thickness was associated with better ETDRS letter scores (r2¼
0.16, P¼ 0.01). Mean fluorescence lifetimes were independent
of the central retinal thickness. Longer lifetimes had a weak but
significant association with thicker subfoveal choroidal thick-
ness (SSC: r2 ¼ 0.13, P ¼ 0.02; LSC: r2 ¼ 0.1, P ¼ 0.045).
Next, we analyzed the seven cases without short autofluo-
rescence lifetimes identifiable within the fovea. In these cases,
the OPL was not identifiable in OCT (Figs. 6A, B).
FLIO in GA Borders
In FLIO, the borders of GA were identified to feature mean
fluorescence lifetime values shorter than within the main
atrophy but longer than the surrounding retina (SSC: 768 6 43
ps, LSC: 736 6 20 ps; all P < 0.0001). In the autofluorescence
intensity images, these intermediate lifetime borders were
located within the hypofluorescent area. In areas of hyper-
fluorescence surrounding the hypofluorescent atrophic areas,
only marginally prolonged mean fluorescence lifetimes were
measured when compared with the surrounding retina (SSC:
78 6 12 ps, LSC: 61 6 8 ps; both P¼ not significant). Adjacent
zones of GA were clearly identifiable in all GA FAF pattern
using two-dimensional (2D) analysis (Fig. 8) and phasor
analysis (Supplementary Fig. S1).20
Analysis of Individual Fluorescence Lifetime
Components
Because Tm is a function of individual lifetimes (T1 and T2) and
corresponding amplitudes (a1 and a2), we investigated the
influence of these components toward the changes seen in
Tm. Areas outside GA showed a characteristic distribution of
the short lifetime component T1 versus the long component
T2, which is depicted in a uniform distribution cloud within
the 2D histogram in both spectral channels (Fig. 8). Areas with
GA typically showed prolonged lifetime components, especial-
FIGURE 2. Classification of FAF patterns according to Bindewald et al.6 Corresponding autofluorescence intensity and mean autofluorescence
lifetime images are shown for each subgroup. (Color scale always 200–1000 ps). GPS, granular with peripheral punctuate spots.
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ly T2, resulting in an overall increase of the mean fluorescence
lifetime Tm. A separate lifetime entity was identified for image
pixels located in the adjacent zone of atrophy.
Within GA, the shortest Tm values from the macular center
resulted from a short T1 component with a high amplitude a1,
whereby T2 was equally distributed within the whole area of
GA.
DISCUSSION
Time-resolved autofluorescence lifetime characteristics within
areas of GA were investigated in a cohort of 41 patients with
dry AMD. Areas of GA featured significantly longer retinal
autofluorescence lifetimes when compared with the surround-
ing retinal tissue. There is a certain degree of variability of
absolute FAF lifetimes between different patients because of
various factors such as lens status. Because of this, data analysis
within individual patients and comparisons of diseased tissue
with surrounding unaffected retina was performed.
The adjacent zone bordering on areas of atrophy was clearly
identifiable using 2D analysis of fluorescence lifetime values.
These diagrams allow for differentiation and visualization of
potential tissue at risk for GA known from FAF intensity studies
as hyperautofluorescent areas.21,22 The main fluorescence
within the retina originates from lipofuscin, a complex mixture
of bisretinoid fluorophores from the visual cycle metabo-
lism.9,23 According to conventional opinion, hyperfluorescent
borders around GA are supposed to contain increased
concentrations of lipofuscin.24 However, in FLIO measure-
ments, corresponding mean fluorescence lifetime values still
differ only marginally from values of the surrounding normal
retina even though significantly prolonged lifetimes originating
from lipofuscin (1262 ps) derivates might be expected.25,26
Rather, new insights indicate that increased autofluorescence
might be caused by vertically superimposed cells and cellular
fragments and not by increased lipofuscin concentrations.12,27
This hypothesis can be supported by our fluorescence lifetime
measurements of these areas.
Typically areas of GA show loss of the RPE and the
overlaying photoreceptors in OCT. In FLIO, this absence may
allow increased contribution of autofluorescence decay times
from retinal layers or metabolites with relatively longer
lifetimes. They may either originate from the underlying
choroid or from within the inner retinal layers. On the other
hand, the presence of long lifetimes in patients with GA
supports our hypothesis that short decay times mainly come
from the RPE. However, in areas of generalized RPE atrophy in
FAF and OCT, we found preservation of relatively short
autofluorescence lifetimes. A recent study has provided
evidence for a strong impact of macular pigment (MP) on
macular FAF lifetimes by correlating MP optical density
measurements with lifetimes in the fovea.28 MP consists of
the two hydroxycarotenoids, lutein and zeaxanthin, with peak
concentrations in the foveal center of the macula.29 MP is very
effective at absorbing short-wavelength blue light with an
absorbance peak at 460 nm.30,31 This can be seen in FAF,
where MP is known to decrease an autofluorescence intensity
signal, resulting in the typical hypofluorescent macula by
absorbing the short-wavelength excitation light. There is little
information on the behavior of MP in GA in the literature,
presumably because the absence of autofluorescence is
masked by the general hypofluorescence caused by GA.
Assuming that short lifetimes in the fovea are generated by
FIGURE 3. Quantitative analysis of autofluorescence decay times in eyes with dry AMD. (A) Mean autofluorescence lifetimes of the macular center,
unaffected retina and within areas of GA for both spectral channels (mean6 SEM; *P < 0.05, ***P < 0.0001, n¼41). (B) For data analysis, a standard
ETDRS grid was used (d¼ 1, 3, and 6 mm). Small areas (circle diameter: 0.2 mm) within the macular center (M) and the OR from unaffected retina
(R) and GA were investigated. AF, fundus autofluorescence intensity LSC; C, center; FLIO SSC/LSC, fluorescence lifetime images of the short and the
long spectral channels; IR, inner ring; ns, not significant; OR, outer ring.
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MP, it is a striking finding that MP is preserved even in the
presence of atrophy. Given that MP is mainly found in the
plexiform layers and the photoreceptor axon layers, the
persistence of MP may reflect the health of the plexiform
layers. Interestingly, in some cases the characteristic short
lifetimes were absent in the fovea. Correlation with OCT in
these cases showed loss of the ONL and OPL within the area of
GA. This strongly supports the evidence that short fluores-
cence lifetimes within the macular center originate from MP.
However, given the persistence of short lifetimes even in the
presence of central atrophy, short central retinal fluorescence
lifetimes alone cannot be used for differentiation of foveal
sparing.
In keeping with these findings, long fluorescence lifetimes
in patients with central GA were associated with worse visual
acuity and thinner subfoveal choroidal thickness. Both findings
may point toward an advanced disease stage of GA. These
results are in accordance with other studies in which the
thinning of the choroid in patients with GA was found32–34 and
even an association with the progression rate was identified.32
In this late stage, the layer structure of the other retinal layers is
mostly destroyed including the Henle fiber layer and the OPL
containing the macular pigment.
An advantage of time-resolved autofluorescence is the
ability to investigate various lifetime components because Tm
is a function of individual lifetimes and amplitudes. The
individual clustering of pixel values in specific regions can be
analyzed using 2D analysis. It is noteworthy that the lifetime
cloud of the adjacent zone falls between the surrounding retina
and the atrophic zone, which implies that the adjacent zone is
influenced by fluorophores that predominate the atrophic
area. In this context, a high spatial resolution of FLIO images is
important, and therefore the curve-fitting parameters we
applied seem to be appropriate.
Our findings of fluorescence lifetime measurement in GA
may have an important impact on disease monitoring because
they may be an indicator for degenerative processes in the
outer retina.
This study shows a broad range of clinical presentations of
GA. However, the number of included patients is limited and
larger cohorts will have to be analyzed to investigate and
evaluate pattern-specific characteristics in the different GA
subgroups. Furthermore, additional ex vivo lifetime data will
be necessary to dissect the influence of individual components
within the border zone of atrophy and the surrounding retina.
In addition, longitudinal follow-up examinations and further
FIGURE 4. Fluorescence lifetimes within GA. (A) FLIO SSC and OCT scans of indicated lines 1 to 6. (B) Correlation of mean fluorescence lifetimes of
the short (above) and long (below) spectral channel with central retinal thickness (dotted line, not significant) and central choroidal thickness (gray
line, SSC: r2 ¼ 0.13, P¼ 0.02; LSC: r2 ¼ 0.1, P ¼ 0.045). AF, fundus autofluorescence intensity; CF, color fundus.
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correlation with functional parameters are needed to identify
markers for disease progression.
CONCLUSIONS
Fluorescence lifetime analysis of areas with GA provides
specific lifetime patterns. Short fluorescence lifetimes within
the macular center may provide information about the integrity
of the OPL and ONL. The analysis of GA borders by FLIO might
emerge as a useful tool for the visualization of local tissue
remodeling and disease monitoring.
FIGURE 5. GA with foveal sparing. (A) OCT scan of the indicated line.
(B) Comparison of fluorescence lifetimes within the foveal center in
eyes with foveal sparing (F’spare) and central atrophy (GA) (n ¼ 10
F’spare; n ¼ 31 GA). AF, fundus autofluorescence intensity LSC; CF,
color fundus; FLIO SSC/LSC, mean fluorescence lifetime images of the
short and the long spectral channels; ns, not significant.
FIGURE 6. FLIO (SSC) and OCT in GA without short central
autofluorescence lifetimes. (A, B) The ONL and the OPL are
completely missing within the area of GA. (C) Example with preserved
ONL and OPL and short mean autofluorescence lifetimes within the
foveal center.
FIGURE 7. Correlation of mean fluorescence lifetime values with best
corrected visual acuity (BCVA, ETDRS letters). Mean values from the
central subfield with error bars (95%, dotted lines) are shown for the
short and the long spectral channels (both r2¼ 0.19, P¼ 0.004). SSC¼
black; LSC ¼ gray.
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